Next-Generation Immune Cell Engagers: From T-Cell Bispecifics to Myeloid and mRNA-Delivered Modalities

• End-to-end antibody solution: Powered by the Harbour Mice® platform for fully human antibodies, Nona Biosciences offers an “Idea-to-Clinic” solution spanning discovery, engineering, and binder optimization
• HBICE® engager platform: Combines this expertise with an off-the-shelf library of TAA and effector arms to deliver transformative bispecific and multispecific immune cell engagers
• Next-generation formats: The small size, flexibility, and modularity of HCAbs enable advanced engagers – biparatopic, mRNA-delivered RiboHBICE®, conditionally active, TCR-mimics (TCRm), and myeloid cell engagers

Speakers:

Sean Cullen

Director, Licensing and Corporate Strategy

Nona Biosciences